"
Autologous Peripheral Blood Stem Cells and γ/δ T Cells May Improve Immunity in Treating Secondary Bacteremic Infection in HIV Infected Patient"
written by Ciro Gargiulo, Van Hung Pham, Nguyen Thuy Hai, Kieu C. D. Nguyen, Ngan Duong Kim, Thinh Nguyen Van, An Luu Tuan, Kenji Abe, Veronica Flores, Melvin Shiffman,
published by
Stem Cell Discovery,
Vol.5 No.4, 2015
has been cited by the following article(s):
|
[1]
|
The Anti-Viral Activity of Stem Cells: A Rational Explanation for their Use
in Clinical Application
Endocrine, Metabolic & Immune Disorders - Drug Targets,
2023
DOI:10.2174/1871530323666221117094330
|
|
|
|
|
[2]
|
New Translational Trends in Personalized Medicine: Autologous Peripheral Blood Stem Cells and Plasma for COVID-19 Patient
Journal of Personalized Medicine,
2022
DOI:10.3390/jpm12010085
|
|
|
|
|
[3]
|
Mesenchymal Stem Cells: The Secret Children’s Weapons against the SARS-CoV-2 Lethal Infection
Applied Sciences,
2021
DOI:10.3390/app11041696
|
|
|
|
|
[4]
|
Sars-CoV-2 Virus Infection May Interfere CD34+ Hematopoietic Stem Cells and Megakaryocyte–Erythroid Progenitors Differentiation Contributing to Platelet Defection towards Insurgence of Thrombocytopenia and Thrombophilia
Microorganisms,
2021
DOI:10.3390/microorganisms9081632
|
|
|
|